The OmniaSecure defibrillation lead from Medtronic is already approved for placement in the right ventricle. This latest approval covers the left bundle branch area, opening the door for conduction system pacing and other advanced techniques.
The COVID-19 pandemic created a major shift in how telehealth services were being utilized. Those services were used much more often for some patient populations than others.
The incident left John Douglas Cox, a mechanic in Washington’s Clark County, partially paralyzed after physicians failed to promptly diagnose and treat a spinal infection.
The federal regulatory agency that exists to protect consumers and promote competition across the economy is newly focused on patients and clinicians as well as taxpayers.
California-based Reflow Medical gained the approval after submitting data from the DEEPER REVEAL clinical trial. The device was associated with a high success rate and improved outcomes in CLTI patients.
Mayo Clinic is looking to give promising medtech startups a seriously running start. Toward that end, the august institution has launched the new Mayo Venture Partner program.
